Skip to main content
Caplight Logo









The Path

The Path

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://thepath.ai

Last Round

Seed

May 21, 2026

Total Funding Raised

$14.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

The Path operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in May 2026.

The Path is a health tech company that provides a global AI therapy platform designed for creating long-term mental wellness.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, NLP & Conversational AI, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Freemium

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

The Path Comparables

Compare The Path with similar companies based on industry and business-model similarity.

The Path comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sonia AI
93%
Noah AI
88%
Youper
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

The Path Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 21, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

The Path Investors

Notable investors and investment history

The Path investors
InvestorRounds
Designer FundSeed
Prime Movers LabSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Tony Robbins identified as a co-founder.

  • Jun 25, 2026

    Plans to scale from ~15 to 50 people in the next year.

Book a demo to see all signals

For institutional investors. Book with your work email.

The Path Filings

Explore SEC and related filing metadata, where available.

The Path filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about The Path's valuation, stock price, and market status.

Is The Path a public or private company?

The Path is a private company.

What is the current stock price of The Path?

The Path is a private company, so its shares have no public market price. Caplight tracks The Path's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is The Path worth (valuation)?

Valuation information for The Path is not publicly available.

Can I buy The Path stock?

The Path shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was The Path's last funding round?

The Path's most recent funding round was Seed on May 21, 2026.

Who are the main investors in The Path?

Key investors in The Path include Prime Movers Lab.

Will The Path IPO soon?

No public IPO plans have been announced for The Path.

How can I track The Path secondary market activity?

Caplight tracks bids, offers, and trades in The Path's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Year FoundedN/A
Last FundingMay 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?